Professor Mohamed Kharfan-Dabaja

Lifetime Achievement International Track

Dr. Mohamed Kharfan-Dabaja is a Professor of Medicine and serves as the Director of the Blood and Marrow Transplantation and Cellular Therapy Program at the Mayo Clinic in Florida, where he is also the vice-Chair of Hematology and the Medical Director of the Cancer Research Office. Dr. Kharfan-Dabaja is the founder of the Clinical Chimeric Antigen Receptor T-cell Therapy (CAR T-cell) Program at the Mayo Clinic in Florida, and has served as the principal investigator of various clinical trials evaluating the efficacy of CAR T-cell therapy in patients with relapsed and/or refractory B-cell non-Hodgkin lymphomas and chronic lymphocytic leukemia. He is also a co-inventor of a CAR T-cell product that targets B-cell Activating Factor Receptor (BAFF-R) that is currently being studied in a phase 1 clinical trial in various refractory B-cell lymphoid malignancies. 

He completed his medical education at the American University of Beirut in Lebanon, his Internal Medicine residency at the Good Samaritan Hospital of Maryland, and his fellowship in Hematology and Medical Oncology at the University of Miami, Jackson Memorial Hospital and the Sylvester Comprehensive Cancer Center. 

Dr. Kharfan-Dabaja is published in prestigious journals such as the New England Journal of Medicine, JAMA Oncology, Journal of Clinical Oncology, Blood, Cancer Immunology Immunotherapy, Transplantation and Cellular Therapy, Bone Marrow Transplantation, Hemasphere, the American Journal of Hematology, and the British Journal of Haematology, among others. His publication record includes over 450 peer-reviewed publications and more than 20 book chapters. He has been invited to lecture in leading medical societies and scientific forums worldwide, including the American Society for Transplantation and Cellular Therapy (ASTCT), the European Society for Blood and Marrow Transplantation (EBMT), the Worldwide Network for Blood & Marrow Transplantation (WBMT), the Mexican Society for Cellular Therapy and Bone Marrow Transplantation, the Colombian Society of Hematology and Oncology, the Korean Society of Blood and Marrow Transplantation (KSBMT), the Indian Society for Blood and Marrow Transplantation (ISBMT), the King Hussein Cancer Research Conference, the Annual Saudi Hematology Congress, and the Lebanese Society of Hematology and Blood Transfusion, among others.